Publication:
IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS

Simple item page
dc.conference.dateJUN 01-04, 2022
dc.conference.titleEULAR European Congress of Rheumatology (EULAR)
dc.contributor.authorLopez-Pedrera, C.
dc.contributor.authorMunoz-Barrera, L.
dc.contributor.authorEscudero Contreras, A.
dc.contributor.authorAguirre-Zamorano, M. A.
dc.contributor.authorOrtiz Buitrago, P.
dc.contributor.authorLopez-Medina, C.
dc.contributor.authorCalvo Gutierrez, J.
dc.contributor.authorOrtega Castro, R.
dc.contributor.authorPilar, F. U.
dc.contributor.authorSanchez-Pareja, I.
dc.contributor.authorAbalos-Aguilera, M. C.
dc.contributor.authorBarbarroja Puerto, N.
dc.contributor.authorCollantes Estevez, E.
dc.contributor.authorPerez-Sanchez, C.
dc.contributor.authoraffiliation[Lopez-Pedrera, C.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Munoz-Barrera, L.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Escudero Contreras, A.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Aguirre-Zamorano, M. A.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Ortiz Buitrago, P.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Medina, C.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Calvo Gutierrez, J.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Ortega Castro, R.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Pilar, F. U.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Sanchez-Pareja, I.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Abalos-Aguilera, M. C.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Barbarroja Puerto, N.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes Estevez, E.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Perez-Sanchez, C.] Univ Cordoba, Rheumatol, IIMIBIC Reina Sofia Hosp, Cordoba, Spain
dc.contributor.funderISCIII
dc.contributor.funderFEDER
dc.contributor.funderFundacion Andaluza de Reumatologia (FAR)
dc.contributor.funderConsejeria de Conocimiento, Investigacion y Universidad de la Junta de Andalucia
dc.date.accessioned2023-05-03T13:30:57Z
dc.date.available2023-05-03T13:30:57Z
dc.date.issued2022-06-01
dc.description.abstractBackground: Systemic autoimmune diseases such as Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) are characterised by aberrant autoimmune and inflammatory processes, which are directly associated with the development and progression of these disorders. Novel biomarkers associated with the severity of these diseases are needed to better characterise and monitor their progression as well as to develop new and more effective therapeutic strategies.
dc.identifier.citationLopez-Pedrera C, Muñoz-Barrera L, Contreras AE, Aguirre-Zamorano MÁ, Buitrago PO, López-Medina C, et al. POS0058 IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):245.2-245
dc.identifier.doi10.1136/annrheumdis-2022-eular.4733
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/81/Suppl_1/245.2.full.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20121
dc.identifier.wosID850279000375
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number245-245
dc.publisherBMJ Group
dc.relation.publisherversionhttps://ard.bmj.com/content/81/Suppl_1/245.2.abstract
dc.rights.accessRightsopen access
dc.subjectArthritis, rheumatoid
dc.subjectLupus erythematosus, systemic
dc.subjectReverse transcriptase polymerase chain reaction
dc.subjectCorrelation of data
dc.subject.decsAnticuerpos
dc.subject.decsBiomarcadores
dc.subject.decsOntología de genes
dc.subject.decsProteómica
dc.subject.decsTecnología disruptiva
dc.subject.meshDisruptive technology
dc.subject.meshGene ontology
dc.subject.meshProteomics
dc.subject.meshAntibodies
dc.subject.meshBiomarkers
dc.titleIDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number81
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format
Download

Collections

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario Reina Sofía

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía